SynthesisFrontiers in immunology2025

Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.

Minyong Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.